Selected research
Industry Growth & Trends
Global AI Disease Prediction Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Disease Prediction Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Disease Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Disease Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Disease Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Disease Prediction Software market include IntelliGenes, IBM Watson Oncology, PathAI, Zebra Medical Vision, Siemens Healthineers, GitHub LifeAI, DeepView, Google DeepMind and Binariks, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Disease Prediction Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Disease Prediction Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Disease Prediction Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Disease Prediction Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Disease Prediction Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Disease Prediction Software Market by Company
IntelliGenes
IBM Watson Oncology
PathAI
Zebra Medical Vision
Siemens Healthineers
GitHub LifeAI
DeepView
Google DeepMind
Binariks
Paige.AI
Lunit INSIGHT
Arterys
Winterlight Labs
BrainScope
Livongo
Deep Genomics
IDx-DR
ChestEye
Viz.ai
AI Disease Prediction Software Segment by Type
Cloud-based
On-premises
AI Disease Prediction Software Segment by Application
Cancer
Cardiovascular Disease
Nervous System Disease
Chronic Disease and Metabolic Disease
Others
AI Disease Prediction Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Disease Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Disease Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Disease Prediction Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Disease Prediction Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premises
Applications
- Cancer
- Cardiovascular Disease
- Nervous System Disease
- Chronic Disease and Metabolic Disease
- Others
Companies covered
- IntelliGenes
- IBM Watson Oncology
- PathAI
- Zebra Medical Vision
- Siemens Healthineers
- GitHub LifeAI
- DeepView
- Google DeepMind
- Binariks
- Paige.AI
- Lunit INSIGHT
- Arterys
- Winterlight Labs
- BrainScope
- Livongo
- Deep Genomics
- IDx-DR
- ChestEye
- Viz.ai
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Disease Prediction Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Disease Prediction Software Market Size by Region (2021-2032)
- 1.4.1 Global AI Disease Prediction Software Market Size by Region (2021-2026)
- 1.4.2 Global AI Disease Prediction Software Market Size by Region (2027-2032)
- 1.5 Key Regions AI Disease Prediction Software Market Size (2021-2032)
- 1.5.1 North America AI Disease Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Disease Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Disease Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Disease Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Disease Prediction Software Market Size Growth Rate (2021-2032)
2 AI Disease Prediction Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Cloud-based
- 2.1.2 On-premises
- 2.2 Global AI Disease Prediction Software Market Size by Type
- 2.2.1 Global AI Disease Prediction Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Disease Prediction Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Disease Prediction Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Disease Prediction Software Market Size by Regions
- 2.3.1 North America AI Disease Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Disease Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Disease Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Disease Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Disease Prediction Software Market Size Breakdown by Type (2021-2026)
3 AI Disease Prediction Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Cardiovascular Disease
- 3.1.3 Nervous System Disease
- 3.1.4 Chronic Disease and Metabolic Disease
- 3.1.5 Others
- 3.2 Global AI Disease Prediction Software Market Size by Application
- 3.2.1 Global AI Disease Prediction Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Disease Prediction Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Disease Prediction Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Disease Prediction Software Market Size by Regions
- 3.3.1 North America AI Disease Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Disease Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Disease Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Disease Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Disease Prediction Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Disease Prediction Software Industry Trends
- 4.2 AI Disease Prediction Software Industry Drivers
- 4.3 AI Disease Prediction Software Industry Opportunities and Challenges
- 4.4 AI Disease Prediction Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Disease Prediction Software Revenue (2021-2026)
- 5.2 Global AI Disease Prediction Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Disease Prediction Software Key Company Headquarters & Area Served
- 5.4 Global AI Disease Prediction Software Company, Product Type & Application
- 5.5 Global AI Disease Prediction Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Disease Prediction Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Disease Prediction Software Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Disease Prediction Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 IntelliGenes
- 6.1.1 IntelliGenes Company Information
- 6.1.2 IntelliGenes Business Overview
- 6.1.3 IntelliGenes AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 IntelliGenes AI Disease Prediction Software Product Portfolio
- 6.1.5 IntelliGenes Recent Developments
- 6.2 IBM Watson Oncology
- 6.2.1 IBM Watson Oncology Company Information
- 6.2.2 IBM Watson Oncology Business Overview
- 6.2.3 IBM Watson Oncology AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 IBM Watson Oncology AI Disease Prediction Software Product Portfolio
- 6.2.5 IBM Watson Oncology Recent Developments
- 6.3 PathAI
- 6.3.1 PathAI Company Information
- 6.3.2 PathAI Business Overview
- 6.3.3 PathAI AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 PathAI AI Disease Prediction Software Product Portfolio
- 6.3.5 PathAI Recent Developments
- 6.4 Zebra Medical Vision
- 6.4.1 Zebra Medical Vision Company Information
- 6.4.2 Zebra Medical Vision Business Overview
- 6.4.3 Zebra Medical Vision AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Zebra Medical Vision AI Disease Prediction Software Product Portfolio
- 6.4.5 Zebra Medical Vision Recent Developments
- 6.5 Siemens Healthineers
- 6.5.1 Siemens Healthineers Company Information
- 6.5.2 Siemens Healthineers Business Overview
- 6.5.3 Siemens Healthineers AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Siemens Healthineers AI Disease Prediction Software Product Portfolio
- 6.5.5 Siemens Healthineers Recent Developments
- 6.6 GitHub LifeAI
- 6.6.1 GitHub LifeAI Company Information
- 6.6.2 GitHub LifeAI Business Overview
- 6.6.3 GitHub LifeAI AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GitHub LifeAI AI Disease Prediction Software Product Portfolio
- 6.6.5 GitHub LifeAI Recent Developments
- 6.7 DeepView
- 6.7.1 DeepView Company Information
- 6.7.2 DeepView Business Overview
- 6.7.3 DeepView AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 DeepView AI Disease Prediction Software Product Portfolio
- 6.7.5 DeepView Recent Developments
- 6.8 Google DeepMind
- 6.8.1 Google DeepMind Company Information
- 6.8.2 Google DeepMind Business Overview
- 6.8.3 Google DeepMind AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Google DeepMind AI Disease Prediction Software Product Portfolio
- 6.8.5 Google DeepMind Recent Developments
- 6.9 Binariks
- 6.9.1 Binariks Company Information
- 6.9.2 Binariks Business Overview
- 6.9.3 Binariks AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Binariks AI Disease Prediction Software Product Portfolio
- 6.9.5 Binariks Recent Developments
- 6.10 Paige.AI
- 6.10.1 Paige.AI Company Information
- 6.10.2 Paige.AI Business Overview
- 6.10.3 Paige.AI AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Paige.AI AI Disease Prediction Software Product Portfolio
- 6.10.5 Paige.AI Recent Developments
- 6.11 Lunit INSIGHT
- 6.11.1 Lunit INSIGHT Company Information
- 6.11.2 Lunit INSIGHT Business Overview
- 6.11.3 Lunit INSIGHT AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Lunit INSIGHT AI Disease Prediction Software Product Portfolio
- 6.11.5 Lunit INSIGHT Recent Developments
- 6.12 Arterys
- 6.12.1 Arterys Company Information
- 6.12.2 Arterys Business Overview
- 6.12.3 Arterys AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Arterys AI Disease Prediction Software Product Portfolio
- 6.12.5 Arterys Recent Developments
- 6.13 Winterlight Labs
- 6.13.1 Winterlight Labs Company Information
- 6.13.2 Winterlight Labs Business Overview
- 6.13.3 Winterlight Labs AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Winterlight Labs AI Disease Prediction Software Product Portfolio
- 6.13.5 Winterlight Labs Recent Developments
- 6.14 BrainScope
- 6.14.1 BrainScope Company Information
- 6.14.2 BrainScope Business Overview
- 6.14.3 BrainScope AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 BrainScope AI Disease Prediction Software Product Portfolio
- 6.14.5 BrainScope Recent Developments
- 6.15 Livongo
- 6.15.1 Livongo Company Information
- 6.15.2 Livongo Business Overview
- 6.15.3 Livongo AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Livongo AI Disease Prediction Software Product Portfolio
- 6.15.5 Livongo Recent Developments
- 6.16 Deep Genomics
- 6.16.1 Deep Genomics Company Information
- 6.16.2 Deep Genomics Business Overview
- 6.16.3 Deep Genomics AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Deep Genomics AI Disease Prediction Software Product Portfolio
- 6.16.5 Deep Genomics Recent Developments
- 6.17 IDx-DR
- 6.17.1 IDx-DR Company Information
- 6.17.2 IDx-DR Business Overview
- 6.17.3 IDx-DR AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 IDx-DR AI Disease Prediction Software Product Portfolio
- 6.17.5 IDx-DR Recent Developments
- 6.18 ChestEye
- 6.18.1 ChestEye Company Information
- 6.18.2 ChestEye Business Overview
- 6.18.3 ChestEye AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 ChestEye AI Disease Prediction Software Product Portfolio
- 6.18.5 ChestEye Recent Developments
- 6.19 Viz.ai
- 6.19.1 Viz.ai Company Information
- 6.19.2 Viz.ai Business Overview
- 6.19.3 Viz.ai AI Disease Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Viz.ai AI Disease Prediction Software Product Portfolio
- 6.19.5 Viz.ai Recent Developments
7 North America
- 7.1 North America AI Disease Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Disease Prediction Software Market Size by Country (2021-2026)
- 7.3 North America AI Disease Prediction Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Disease Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Disease Prediction Software Market Size by Country (2021-2026)
- 8.3 Europe AI Disease Prediction Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Disease Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Disease Prediction Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Disease Prediction Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Disease Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Disease Prediction Software Market Size by Country (2021-2026)
- 10.3 South America AI Disease Prediction Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Disease Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Disease Prediction Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Disease Prediction Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst